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INTRODUCTION
Hypoxia, which is a loss of oxygen in tissues, is a common 
condition in solid tumors that occurs when tumors outgrow 
existing vasculature [1,2]. Oxygen tension is approximately 7% 
in normal tissues and 1.3% in solid tumors [3,4]. Tumor cells 
can survive under hypoxic conditions by adapting to low oxy-
gen tension or by increasing vascularization. Among the genes 
involved in tumor angiogenesis, vascular endothelial growth 
factor (VEGF) is the most investigated and anti-VEGF anti-
body (Avastin
TM) is now available to treat various cancers.
Another major regulator used by cancer cells to adapt to 
hypoxia is the transcription factor hypoxia-inducible factor-1 
(HIF-1). HIF-1 is composed of an HIF-1α and an HIF-1β sub-
unit. Unlike the oxygen regulated HIF-1α subunits, HIF-1β is 
constitutively expressed and not responsive to oxygen concen-
trations. Of the HIF-1 subunits, HIF-1α is the most ubiquitous-
ly expressed, and functions as the master oxygen homeostasis 
regulator of in many cell types [5,6]. Under normoxic condi-
tions, HIF-1α is hydroxylated and binds to von Hippel-Lindau 
tumor suppressor protein (pVHL), which in turn targets HIF-
1α for degradation [7,8]. In contrast, HIF-1α rapidly accumu-
lates and transactivates hundreds of genes under hypoxic con-
ditions, including angiogenic and growth factors and receptors, 
and extracellular proteases such as matrix metalloproteinases 
(MMPs) [9,10].
MMPs are endopeptidases that degrade most of the com-
ponents of the extracellular matrix (ECM), including the base-
ment membrane (BM). MMPs are overexpressed in various 
solid tumors, including breast cancer, and are recognized to 
play important roles in many steps of the metastatic process. 
MMPs contribute to invasion and metastasis of tumor cells by 
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Purpose: Hypoxia, which is a loss of oxygen in tissues, is a com-
mon condition in solid tumors due to the tumor outgrowing ex-
isting vasculature. Under hypoxic conditions, hypoxia-inducible 
factor (HIF)-1α rapidly accumulates and transactivates hundreds 
of genes, such as matrix metalloproteinases (MMPs). MMPs con-
tribute to invasion and metastasis of tumor cells by degrading 
the surrounding basement membrane and extracellular matrix 
barriers, which enables the easy migration and spread of cancer 
cells. We examined whether hypoxia increases tumor cell inva-
sion, and whether increased invasiveness was due to HIF-1α and 
MMP-9 expression. Methods: Transwell invasion assays were 
performed to demonstrate whether hypoxia enhance tumor in-
vasion by use of MDA-MB-231 breast cancer cells. An immuno-
fluorescence assay was used to demonstrate expression of HIF-
1α and MMP-9 under hypoxic conditions. Luciferase and ChiP 
assays were performed to demonstrate that MMP-9 promoter 
activity was regulated by HIF-1α. Results: HIF-1α was stabilized 
under hypoxic conditions and stimulated MMP-9 expression, which 
affected the tumor invasiveness of breast cancer cells. HIF-1α 
transactivated the MMP-9 promoter by forming a transcriptional 
unit with p300, thus increasing expression of MMP-9 transcripts. 
Zymography indicated that MMP-9 had more gelatinase activity 
under hypoxic conditions than normoxic conditions. Furthermore, 
the small GTPase Ras was also activated in response to hypoxia, 
which then aids stabilization of HIF-1α, and in turn upregulates 
MMP-9 expression. We also demonstrate that MMP-9 is upreg-
ulated concurrently with HIF-1α in tumor tissues from patients with 
breast cancer. Conclusion: These results suggest that HIF-1α pro-
motes cell invasion through a MMP-9-dependent mechanism and 
that future antitumor agents could be used to target HIF-1α and 
MMP-9.
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degrading the surrounding BM and ECM barriers, which then 
enables the easy migration and spread of cancer cells. MMPs 
are also involved in the regulation of cell proliferation, release 
of growth factors and angiogenesis [11,12]. MMP activity is 
controlled by the proteolytic cleavage of inactive proforms into 
mature active forms and by interaction with the endogenous 
tissue inhibitors of metalloproteinases.
HIF-1α is overexpressed in primary breast cancers [13]. In-
creased MMP expression and activation are correlated with in-
creased metastatic potential and poor prognosis in breast can-
cer [14,15]. Recent studies have also correlated HIF-1α with 
VEGF gene expression in human breast cancer [16]. Further-
more, HIF-1α is upregulated regardless of human epidermal 
growth factor receptor 2 (HER2)/c-erb2 expression or estrogen 
receptor (ER) status [13,17].
Hypoxia stimulates tumor angiogenesis and metastasis via 
HIF-1α [3,10]. Many reports suggest that hypoxia and HIF-1 
upregulate expression and/or activity of MMPs, and that a high 
level of HIF-1α at diagnosis is predictive of early relapse and 
metastatic disease, and correlates with poor outcomes [18,19]. 
In many cancer tissues and cells, MMPs are differentially ex-
pressed and have various functions [20,21]. However, little is 
known about how HIF-1α regulates MMP expression to en-
hance tumor cell invasion. Among MMPs, MMP-9 has been 
positively correlated with a higher incidence of metastases in 
breast or lung cancer [20,22,23]. In this study, we examined 
whether hypoxia increases tumor cell invasion, whether in-
creased invasiveness is due to MMP-9 expression, and exam-
ined the role that the Ras gene plays in the process.
METHODS
Reagents
CoCl2, desferoxamine (DFO), and MG132 were purchased 
from Sigma Chemical Co. (St Louis, USA). Antibodies against 
HIF-1α, MMP-9, p-ERK, ERK and tubulin were purchased 
from Santa Cruz Biotechnology (Santa Cruz, USA). Antibod-
ies against Ras and GST-Raf1-PBD were purchased from Up-
state Biotechnology (Lake Placid, USA). TRITC- and FITC-
conjugated secondary antibodies were purchased from Jack-
son ImmunoResearch (West Grove, USA).
Cell culture
The MDA-MB-231 breast cancer cell line and NCI-H-1299 
lung cancer cell line were grown in Dulbecco’s modified Eagle’s 
medium supplemented with 5% fetal bovine serum at 37°C 
and 5% CO2.
Hypoxic and normoxic conditions
Hypoxic conditions were created in an airtight chamber de-
oxygenated with the constant infusion of a hypoxic gas mix-
ture (37°C, 5% CO2, 1% O2, 94% nitrogen). The O2 content was 
monitored with an O2-analyzer. Similarly, normoxic conditions 
were maintained in a standard incubator (37°C, 5% CO2, 20% 
O2, balanced N2).
Invasion assay
Matrigel invasion assays were performed using modified 
Boyden chambers with polycarbonate nucleopore membranes 
(Corning, USA). CoCl2 and DFO were used to create hypoxic 
conditions. First, pre-coated filters (6.5 mm in diameter, 8-μm 
pore size, Matrigel 100 μg/cm
2) were rehydrated with 100 μL 
media. Cells in 200 μL serum-free medium were seeded into 
the upper part of the chamber, and the lower compartments 
were filled with 1 mL serum-free media. Following a 24-hour 
incubation at 37°C, non-invaded cells on the upper surface of 
the filter were wiped off with a cotton swab, and the invaded cells 
on the lower surface of the filter were fixed and stained with 
hematoxyline. Invasiveness was determined by counting cells in 
four microscopic fields per well, and the extent of invasion was 
expressed as an average number of cells per microscopic field.
RT-PCR
Total RNA was extracted using TriZol reagent (Invitrogen 
Life Technologies, Carlsbad, USA) and used for reverse tran-
scription polymerase chain reaction (RT-PCR). Briefly, RNA 
was reverse-transcribed with the Murine-Moloney leukemia 
virus using oligo-dT primer. PCR was performed over 30 cy-
cles of sequential reactions: 94°C for 30 seconds, 55°C for 30 
seconds, and 72°C for 30 seconds. Oligonucleotide primers 
were purchased from Bioneer (Seoul, Korea). PCR primer se-
quences are described in Table 1.
Table 1. Primer sequence (5´-3´ orientation)
Name Primers
MMP-1
 
ATTGGAGCAGCAAGAGGCTGGGA
TTCCAGGTATTTCTGGACTAACT
MMP-2
 
CACAGCCAACTACGATGACG
CTCCTGAATGCCCTTAGATGT
MMP-3
 
AGCATAGAGACAACATAGAGCT
TTCTAGATATTTCTGAACAAGG
MMP-9
 
GGCCCTTCTACGGCCACT
CAGAGAATCGCCAGTACTT
TIMP-2
 
GATGCACATCACCCTCTGTG
GTGCCCGTTGATGTTCTTCT
TIMP-3
 
CGCTGGTCTACACCATCAAGC
CAGGAGGATAGTTCCCAATAAACC
MMP=matrix metalloproteinase; TIMP=tissue inhibitor of metallopro-
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Western blot analysis
Cell extracts for Western blotting were prepared in modi-
fied RIPA buffer (50 mM Tris-HCl [pH 7.4], 1% Nonidet P-40 
[NP-40], 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM 
Na3VO4, 1 mM NaF, 2 mM phenylmethylsulfonylfluoride, 100 
µg/mL leupeptin, 10 µg/mL pepstatin, 1 µg/mL aprotinin, and 
2 mM EDTA). Proteins in lysates were separated by SDS-PAGE 
and transferred to a nitrocellulose membrane. After transfer, 
the membrane was soaked in a blocking buffer (20 mM Tris 
base [pH 7.5], 137 mM NaCl, 0.1% Tween 20, and 5% nonfat 
milk) to prevent nonspecific binding, incubated with primary 
antibodies for 1 hour at room temperature, and then washed 
with TBS-T. Then, the membrane was incubated with peroxi-
dase-conjugated secondary antibodies, washed, and visualized 
using an ECL system (Amersham, Piscataway, USA).
Zymography
MDA-MB-231 cells were incubated under normoxic or hy-
poxic conditions for 24 hours and the cell culture medium sam-
ples were collected. Samples were loaded on denaturing 8% 
polyacrylamide-SDS-gels containing 0.1% gelatin to measure 
gelatinase activity. Gels were washed in distilled water and in-
cubated in 2.5% Triton-X100 for 1 hour to remove SDS, and 
then incubated overnight at 37°C in an assay buffer (50 mM 
Tris-HCl [pH 7.3], 200 mM NaCl, 5 mM CaCl2, and 0.02% 
Brij-35). The reaction was stopped by staining the gels with 
0.1% Coomassie Brilliant Blue and the gelatinase activity was 
detected as clear bands against the aquablue stained gelatin 
background.
Immunofluorescence staining
MDA-MB-231 and NCI-H-1299 cells were plated on slides. 
After an incubation under hypoxic conditions, cells were pre-
incubated with solutions containing 5% normal goat serum, 
2% BSA, and 0.1% Triton X-100 for 1 hour at room tempera-
ture. MMP-9 (1:500) or HIF-1α (1:500) antibodies were used. 
Cells were incubated overnight at 4°C with each antibody, and 
then washed and incubated for 1 hour with TRITC- and FITC-
conjugated secondary antibody (1:200) at room temperature. 
Images were captured using an imaging system (KAPPA Im-
ageBase DX 30; KAPPA Opto-Electronic Inc., Boca Raton, 
USA).
GST-Raf1-PBD binding assay
MDA-MB-231 cells were incubated for 1 hour in a hypoxia 
chamber, and lysed with lysis/binding/wash buffer (25 mM 
Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM MgCl2, 1% NP-40,   
1 mM DTT, and 5% glycerol), and then GST-Raf1-PBD con-
jugated to glutathione-agarose beads was added to the cell ly-
sates to collect activated Ras. After a 1 hour incubation at 4°C, 
the beads were washed with lysis/binding/wash buffer, resus-
pended in 2× SDS sample buffer, and electrophoresed on 12% 
SDS-PAGE. Ras-GTP was detected by Western blotting using 
a mouse monoclonal anti-Ras-antibody.
Luciferase reporter assay
MDA-MB-231 cells were transiently transfected with MMP-
9-Luc using Lipofectamine reagents, and all clones were cotrans-
fected with pCMV-β-galactosidase to normalize cell number 
and transcription variation. After 24 hours, the cells were washed 
with ice-cold PBS and lysed with 100 µL of lysis buffer. To mea-
sure luciferase activity, 20 µL of cell extracts were mixed in 100 
µL of assay buffer, and read with a luminometer (Berthold Lu-
mat LB9501; Berthold Technologies, Oak Ridge, USA). Lucif-
erase activity was normalized by measuring the β-galactosidase 
activity at 420 nm.
Chromatin immunoprecipitation assay (ChIP assay)
MDA-MB-231 cells were incubated under hypoxic condi-
tions for 6 hours, fixed with formaldehyde, and sonicated to 
prepare the chromatin sample. Chromatin samples were im-
munoprecipitated with antibodies against HIF-1α, p300, Ac-
H3, Ac-H4 or normal rabbit IgG antibodies at 4°C for 3 hours. 
Immunoprecipitated DNA was amplified by PCR.
RESULTS
Hypoxia enhances tumor invasion by inducing MMPs
Hypoxia-induced MDA-MB-231 cells showed marked in-
vasion that increased by more than 7-fold compared to cells 
under normoxic conditions (Figure 1). We examined whether 
hypoxic conditions increased MMP expression. MMP-1, MMP-
2, MMP-3, MMP-9, TIMP-2, and TIMP-3 were all silent un-
der normoxic conditions, but were highly transcribed under 
hypoxic conditions, suggesting that hypoxia enhances tumor 
invasion by inducing MMP expression (Figure 2).
Hypoxia induces MMP-9 expression via HIF-1α induction
MDA-MB-231 and NCI-H-1299 cells were incubated in the 
presence or absence of CoCl2 or DFO, and total proteins were 
extracted and analyzed by Western blotting using HIF-1α or 
MMP-9 antibody. CoCl2 or DFO enhanced HIF-1α and MMP-
9 induction in both cell lines (Figure 3A).
Transfected HIF-1α wt DNA construct was incubated in the 
presence of protease inhibitor, MG132 to demonstrate whether 
HIF-1α directly induced MMP-9 expression. As shown in Fig-
ure 3B, CoCl2 induced HIF-1α and MMP-9 expression, and 
HIF-1α wt-expressing cells incubated with MG132 showed Overexpression of MMP-9 and HIF-1α in Breast Cancer Cells  91
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enhanced HIF-1α and MMP-9 induction. An immunofluo-
rescence assay was used to confirm expression of HIF-1α and 
MMP-9 under hypoxic conditions. HIF-1α and MMP-9 im-
munoreactivity were found under hypoxic conditions, but not 
normoxic conditions (Figure 4). As MMP-9 acts by cleavage 
from pro-MMP-9, a zymography assay was used to test MMP-9 
activity in hypoxic condition. MMP-9 activity was also higher 
under hypoxic conditions, as previously described (Figure 3C).
Ras-GTP induces HIF-1α induction, and consequently leads to 
MMP-9 gene expression
As shown in Figure 5A, hypoxia resulted in the activation of 
Ras and the downstream signaling molecule, p42/p44, in MDA-
MB-231 cells. To confirm the relationship between Ras, HIF-
1α and MMP-9, transfected HIF-1α wt, SiHIF-1α, Ras DN or 
Ras Ac were incubated in the presence or absence of MG132 
or CoCl2. HIF-1α and MMP-9 were enhanced in Ras Ac-       
expressing cells without CoCl2, indicating that Ras contributes 
to HIF-1α stabilization and leads to MMP-9 gene expression. 
But, MMP-9 was not induced by CoCl2 in SiHIF-1α- or Ras DN-
expressing cells (Figure 5B).
HIF-1α and Ras regulate MMP-9 promoter activity
Based on the results above, we found that hypoxia induced 
MMP-9 expression at the transcriptional level via Ras and HIF-
1α. To further confirm whether Ras and HIF-1α regulate MMP-
9 promoter activity under hypoxic conditions, we measured 
MMP-9 promoter activity in MDA-MB-231 and NCI-H-1299 
cells. MDA-MB-231 cells were transiently transfected with a 
MMP-9 luciferase reporter gene, and HIF-1α wt, SiHIF-1α, Ras 
Figure 2. Hypoxia enhances tumor cell invasion through matrix metallo-
proteinases (MMPs). MDA-MB-231 cells were incubated under normox-
ic and hypoxic conditions for 24 hours, and then total RNA was isolated. 
MMP-1, MMP-2, MMP-3, MMP-9, TIMP-2, and TIMP-3 levels were an-
alyzed using reverse transcription polymerase chain reaction. GAPDH 
was used as a control.
TIMP=tissue inhibitor of metalloproteinase; VGEF=vascular endothelial 
growth factor; GAPDH=glyceraldehyde-3-phosphate dehydrogenase.
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Figure 1. Hypoxia enhances tumor cell invasion. (A) MDA-MB-231 cells were incubated in transwell chamber under normoxic and hypoxic conditions 
for 24 hours, and the cells were stained with hematoxyline. (B) Invaded cells were counted in four microscopic fields per well.92   Jae Young Choi, et al.
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Ac or Ras DN were used to evaluate its role in MMP-9 gene 
induction. MMP-9 promoter activity was higher under hypox-
ic conditions, and MMP-9 showed the same promoter activity 
when HIF-1α was stabilized by incubating with MG132, even 
under normoxic conditions. When HIF-1α was not expressed 
using SiHIF-1α, MMP-9 promoter activity was low, indicating 
that MMP-9 promoter activity was regulated by HIF-1α. Fur-
thermore, MMP-9 promoter activity was higher in Ras Ac- 
expressing cells than in Ras DN-expressing cells, suggesting 
that Ras-GTP contributes to MMP-9 promoter activity via 
HIF-1α stabilization (Figure 6A).
NCI-H-1299 cells were also examined, and similar results 
were observed to those of MDA-MB-231 cells (data not shown). 
We performed ChIP assays to further examine whether hypox-
ia changes the chromatin conformation of the MMP-9 gene 
promoter. MDA-MB-231 cells were incubated under hypoxic 
conditions for 6 hours, and chromatin was immunoprecipi-
tated with rabbit IgG, HIF-1α, p300, acetylated-H3 histone or 
acetylated-H4 histone antibody. We found that hypoxia recruit-
ed HIF-1α to the MMP-9 promoter with p300, and led to his-
tone modification via acetylation of histone H3 and H4 (Fig-
ure 6B).
  Con  CoCl2  Con  DFO
  Normoxia  Hypoxia
  Con  CoCl2  HIFwt+MG132
  Con  CoCl2  Con  DFO
MDA-MB-231
Zymography
NCI-H-1299
HIF-1α
HIF-1α
HIF-1α
MMP-9
MMP-9 Gelatinase activity 82 kDa
MMP-9
A
B C
Figure 3. Hypoxia induces matrix metalloproteinase-9 (MMP-9) expression via hypoxia-inducible factor (HIF)-1α induction. (A) MDA-MB-231 cells and 
NCI-H-1299 cells were incubated in the presence or absence of CoCl2 or desferoxamine (DFO), and total proteins were extracted and analyzed by 
Western blotting using HIF-1α antibody. MMP-9 was detected in culture medium. The data shown are representative of three independent experiments. 
(B) MDA-MB-231 cells were transfected with HIF-1α wt DNA construct and incubated in the presence of protease inhibitor, MG132. HIF-1α was de-
tected in cell lysates and MMP-9 was analyzed in culture medium by Western blotting. (C) Zymography assay was used to examine MMP-9 activity. 
MDA-MB-231 cells were incubated under normoxic or hypoxic conditions for 24 hours and cell culture medium samples were collected. Samples were 
loaded on denaturing 8% polyacrylamide-SDS-gel containing 0.1% gelatin. Gels were washed in distilled water and were incubated in assay buffer, 
and then were stained with 0.1% Coomassi Brilliant Blue. Clear band marked in 82 kDa shows the gelatinase activity. 
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Figure 4. Hypoxia induces matrix metalloproteinase-9 (MMP-9) expression via hypoxia-inducible factor (HIF)-1α induction. Immunofluorescence as-
say was performed to examine expression of HIF-1α and MMP-9 in cellular level by imaging. Each slide was stained with antibodies against HIF-1α 
or MMP-9, and then incubated with FITC-conjugated rabbit antibody for HIF-1α or with TRITC-conjugated mouse antibody for MMP-9. Overexpression of MMP-9 and HIF-1α in Breast Cancer Cells  93
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HIF-1α plays a role in tumor invasion by inducing MMP-9 
gene expression in cancer patients
To reaffirm that HIF-1α contributes to MMP-9 gene induc-
tion, we tested the HIF-1α and MMP-9 gene expression level 
in tumor tissue from patients with breast cancer. Among four 
patients, three samples showed that HIF-1α and MMP-9 were 
induced in tumor tissue, but not in normal tissue. These results 
suggest that HIF-1α is necessary for MMP-9 gene expression 
in tumors (Figure 7).
DISCUSSION
In the past, hypoxia was only considered to be a predictor 
Figure 5. Ras-GTP induces hypoxia-inducible factor (HIF)-1α stabilization, and consequently leads to matrix metalloproteinase-9 (MMP-9) gene ex-
pression. (A) MDA-MB-231 cells were incubated in normoxic or hypoxic conditions for 1 hour (upper panel). Ras activity was measured GTP-Ras 
bound to GST-Ras-PBD fusion protein (low panel). Cell lysates were prepared and Western blotting was performed using antibodies against phos-
pho-ERK or ERK. Tubulin was used as a loading control. (B) MDA-MB-231 cells were transfected with HIF-1α wt, SiHIF-1α, Ras DN or Ras Ac DNA 
construct and incubated in the presence or absence of CoCl2. Total protein was prepared, and Western blotting was performed with HIF-1α antibody. 
MMP-9 was detected in culture medium. Tubulin indicated amount of loading. 
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Figure 6. Hypoxia-inducible factor (HIF)-1α and Ras regulates matrix metalloproteinase-9 (MMP-9) promoter activity. (A) MMP-9 luciferase construct 
was cotransfected with HIF-1α wt, SiHIF-1α, Ras Ac or Ras DN in MDA-MB-231 cells. After 24 hours, cells were incubated in hypoxic condition or 
treated with MG132. Bars represent the average luciferase activity of four independent experiments. β-galactosidase assay were used to normalize 
for transfection efficiencies. NCI-H-1299 cells showed the same results as MDA-MB-231 cells (data not shown). (B) MDA-MB-231 cells were incubat-
ed in the normoxic or hypoxic conditions for 6 hours, and chromatin was immunoprecipitated with Rabbit IgG, HIF-1α, p300, acetylated-H3 histone 
or acetylated-H4 histone antibody. Purified DNA was amplified by semiquantitative polymerase chain reaction (PCR) using MMP-9 primers. Five-fold 
dilutions of DNA were amplified as an internal control of the PCR. 
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Figure 7. Hypoxia-inducible factor (HIF)-1α plays a role in tumor inva-
sion by inducing matrix metalloproteinase-9 (MMP-9) gene expression 
in cancer patients. Tissues from patients with breast cancer and corre-
sponding normal tissues were prepared, and lysed. HIF-1α and MMP-9 
expression were detected by Western blotting (arrows). 
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of poor response to radiotherapy or chemotherapy. However, 
many clinical and experimental studies have shown an associ-
ation between the hypoxic tumor microenvironment, nutrient 
deprivation, and the metastatic process of various solid tumors. 
HIF-1 complex, which is composed of a heterodimer pair of 
HIF-1α and HIF-1β, is a newly researched molecule. When 
cells are hypoxic,-(almost all solid tumors are hypoxic)-, HIF-
1α hydroxylation and pVHL association is lowered and HIF-
1α protein levels rise. HIF-1α protein, with its nuclear localiza-
tion sequence, is then translocated to the nucleus, where it het-
erodimerizes with HIF-1β. The HIF-1α complex binds to hy-
poxic responsive elements and upregulates hypoxic-regulated 
genes, inducing changes that enable tumor cells to survive apop-
tosis, angiogenesis, invasion and metastases [3].
In this study, hypoxia-induced MDA-MB-231 cells showed 
increased invasiveness compared to cells under normoxic con-
ditions. Several studies have described the transcriptional up-
regulation of proteases such as MMP-9 as a mechanism respon-
sible for hypoxia-induced cell invasion and metastasis [24,25] 
MMP-9 overexpression is positively correlated with a higher 
incidence of metastasis in breast and lung cancers [20,22,23]. 
The present study showed that MMP-9 expression was upreg-
ulated by HIF-1α in the MDA-MB-231 breast cancer cell line, 
NCI-H-1299 lung cancer cell line, and breast cancer tissue. This 
means that MMP-9 is an essential component of hypoxia-in-
duced invasion in breast cancer cells. We have also shown that, 
hypoxic microenvironments in human breast tumors are cor-
related with MMP-9 activity. Large breast tumors may have 
more severe hypoxic microenvironments that induce cellular 
invasive properties via MMP-9 activation mechanisms, suggest-
ing a higher incidence of metastasis in large primary tumors. 
Quantified data on the expression of MMP-9 in various sizes 
of tumors are needed to evaluate this hypothesis.
In contrast, the Ras gene is involved in this process. The Ras 
oncogene is active and relevant in about 30% of human cancers, 
and it plays a role in tumor cell invasion [26]. Several investi-
gators have recently shown that Ras affects VEGF expression 
through HIF-1α [27]. This interaction is mediated through ty-
rosine kinase signaling via murine leukemia viral oncogene 
homolog 1/map/ERK kinase-1/extracellular signal-regulated 
kinase (Raf/MEK1/ERK), a pathway shared with AKT [28]. 
HIF-1α and MMP-9 were enhanced in Ras Ac-expressing cells 
without CoCl2, indicating that Ras contributes to HIF-1α sta-
bilization and leads to MMP-9 gene expression. To further eval-
uate whether Ras and HIF-1α regulate MMP-9 promoter activ-
ity under hypoxic conditions, we measured the MMP-9 pro-
moter activity using the luciferase and ChIP assays. Our results 
showed that MMP-9 promoter activity was higher in Ras Ac-
expressing cells than in Ras DN-expressing cells, suggesting that 
Ras-GTP contributes to MMP-9 promoter activity via HIF-1α 
stabilization.
Based on these results, HIF-1α, MMP-9 and Ras seem to be 
promising therapeutic targets in breast cancer research. Many 
approaches have been considered to identify agents that reduce 
HIF-1α protein levels given the overexpression of HIF-1α in 
so many tumors and association of HIF-1α with tumor angio-
genesis [5,10].
HIF-1α has emerged as an important transcription factor in 
various tumors, especially in breast cancer tumor biology. In 
breast cancer, HIF-1α is a logical target for chemoprevention 
strategies in patients at higher genetic risk for breast cancer. 
Additionally, even though interactions between estrogen in-
tracellular signaling pathways and HIF-1α are still not fully 
defined in breast cancer, ER-β downstream factors are candi-
dates for estrogen modulation of HIF-1α levels. In vitro data on 
breast cancer cell lines shows that c-erbB-2 enhances HIF-1α 
expression [29]. In a clinical study, c-erbB-2 positivity was re-
lated to HIF-1α protein expression and high angiogenesis [30].
Hypoxia promotes tumor invasion, and HIF-1α plays a piv-
otal role. Under hypoxic conditions, HIF-1α is stabilized and 
stimulates expression of MMP-9 gene affecting tumor invasion, 
while Ras is activated, which then aids in stabilizing HIF-1α, 
which in turn upregulates MMP-9 expression. Additional stud-
ies are required to define the interactions between endocrine 
function, endocrine receptors, and HIF-1 transcriptional fac-
tors. Transgenic mouse model experiments and human breast 
cancer studies may help determine whether HIF-1α inhibi-
tors, including 2ME2, the inhibitor for the Ras pathway, and an 
MMP-9 inhibitor decrease invasion or metastases of tumors. 
Furthermore, their chemopreventive effects in genetic high-
risk patients should be evaluated.
In conclusion, hypoxia promoted tumor invasion via HIF-1α. 
HIF-1α was stabilized under hypoxic conditions and stimulat-
ed MMP-9 gene expression, thus affecting tumor invasion in 
several cell lines. HIF-1α trans-activated the MMP-9 promoter 
by forming a transcriptional unit with p300, and thus, increased 
further expression of MMP-9 transcripts. Zymography also 
indicated that MMP-9 has more gelatinase activity under hy-
poxic conditions than normoxic conditions.
Furthermore, small GTPase Ras was also activated in re-
sponse to hypoxia, which aided in the stabilization of HIF-1α, 
and upregulated MMP-9 expression. We demonstrated that 
MMP-9 was upregulated concurrently with HIF-1α in tumor 
tissues from patients with breast cancer.
These results suggest that HIF-1α directly promotes cell in-
vasion through a MMP-9 and Ras dependent mechanism and 
that future anti-tumor agents may target HIF-1α and MMP-9.
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